Literature DB >> 11376946

Transcriptional activity of the SHP-1 gene in MCF7 cells is differentially regulated by binding of NF-Y factor to two distinct CCAAT-elements.

Y Xu1, D Banville, H F Zhao, X Zhao, S H Shen.   

Abstract

Our previous studies have shown that SHP-1, a SH2 domain-containing protein-tyrosine phosphatase, is expressed not only in cells of hematopoietic lineages, but also in many non-hematopoietic cells under the control of an alternative tissue-specific promoter, P1. In this study, the activity of the P1 promoter was analyzed in a region spanning 3.5 kb upstream of the major transcription start site in non-hematopoietic MCF-7 cells. Using DNA footprinting, gel retardation assays and mutational analysis, we have characterized cis-regulatory elements that are essential to confer the P1 promoter activity. An upstream Sp1 element (-126 to -118) positively regulated this TATA-box-lacking promoter. Two inverted CCAAT-elements (-332 to -328 and -66 to -62) played important roles in regulating the SHP-1 gene expression, and transcription factor NF-Y predominantly bound to the two CCAAT-elements. Binding of NF-Y to the distal CCAAT-element enhanced the transcriptional activity of the P1 promoter. In contrast, binding of NF-Y to the proximal CCAAT-element and interacting with repressor(s) inhibited the promoter activity. Furthermore, incubation of MCF7 cells with 100 ng/ml trichostatin A, an inhibitor of histone deacetylase, significantly increased the activity of the P1 promoter. Mutation in the proximal CCAAT-element, however, eliminated the activating effect of trichostatin A on the promoter. Together, our data suggest that NF-Y factor can function either as a specific positive or negative regulator of P1 promoter activity in non-hematopoietic MCF7 cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376946     DOI: 10.1016/s0378-1119(01)00445-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner.

Authors:  Cory T Bernadt; Tamara Nowling; Matthew S Wiebe; Angie Rizzino
Journal:  Gene Expr       Date:  2005

2.  Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia.

Authors:  George P Christophi; Chad A Hudson; Ross Gruber; Christoforos P Christophi; Paul T Massa
Journal:  J Neurochem       Date:  2008-06-01       Impact factor: 5.372

3.  Ultraviolet irradiation represses TGF-β type II receptor transcription through a 38-bp sequence in the proximal promoter in human skin fibroblasts.

Authors:  Tianyuan He; Taihao Quan; Gary J Fisher
Journal:  Exp Dermatol       Date:  2014-10       Impact factor: 3.960

4.  Transcriptional regulation of xyn2 in Hypocrea jecorina.

Authors:  Elisabeth Würleitner; Licia Pera; Christian Wacenovsky; Angela Cziferszky; Susanne Zeilinger; Christian P Kubicek; Robert L Mach
Journal:  Eukaryot Cell       Date:  2003-02

Review 5.  Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1.

Authors:  Florence W L Tsui; Alberto Martin; John Wang; Hing Wo Tsui
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

6.  Autoregulation of mouse histone deacetylase 1 expression.

Authors:  Bernd Schuettengruber; Elisabeth Simboeck; Harald Khier; Christian Seiser
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients.

Authors:  George P Christophi; Chad A Hudson; Ross C Gruber; Christoforos P Christophi; Cornelia Mihai; Luis J Mejico; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2008-01-21       Impact factor: 5.662

8.  Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus.

Authors:  Paul T Massa; Stacie L Ropka; Sucharita Saha; Karen L Fecenko; Kathryn L Beuler
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

Authors:  Lisa M Butler; Xianbo Zhou; Wei-Sheng Xu; Howard I Scher; Richard A Rifkind; Paul A Marks; Victoria M Richon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-20       Impact factor: 11.205

10.  Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype.

Authors:  George P Christophi; Michael Panos; Chad A Hudson; Rebecca L Christophi; Ross C Gruber; Akos T Mersich; Scott D Blystone; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.